Latest Food & Drug Administration news
FDA Approves Omicron-Specific Booster Shots From Pfizer, Moderna
posted August 31st
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Imbruvica for Pediatric Chronic Graft Versus Host Disease
posted August 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves First Cell-Based Gene Therapy for Beta-Thalassemia
posted August 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Tabrecta Gains Full FDA Approval for Non-Small Cell Lung Cancer
posted August 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
Gene Mutation Identified That Increases Lung Cancer Risk 
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Lung Transplant Can Prolong Survival in Stage IV NSCLC 
Risk-Based Strategies Superior to USPSTF Criteria for Lung Cancer Screening 
FDA Now Providing Daily Updates on Adverse Events 
FDA Suspends U.S. License of Chikungunya Vaccine 
FDA Urges Restrictions, Education on Illegal 7-OH Opioid Products 
Federal Agencies Working to Create Uniform Definition of Ultra-Processed Foods Monthly Specialist Briefings
Stay Connected
